Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
The DOI matches its Crossref record; 173 of the 174 references it cites were found in a registry or an index.
Abstract
Many studies have shown the central importance of the co-receptors CD28, inducible costimulatory molecule (ICOS) and cytotoxic T lymphocyte antigen 4 (CTLA4) in the regulation of many aspects of T-cell function. CD28 and ICOS have both overlapping and distinct functions in the positive regulation of T-cell responses, whereas CTLA4 negatively regulates the response. The signalling pathways that underlie the function of each of the co-receptors indicate their shared and unique properties and provide compelling hints of functions that are as yet uncovered. Here, we outline the shared and distinct signalling events that are associated with each of the co-receptors and provide unifying concepts that are related to signalling functions of these co-receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mouse and human T cells the dimeric transmembrane glycoprotein CD28 represents the most important co-stimulatory molecule.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
In the citing paper
“Under physiological conditions CD28-derived signals alone are not capable of inducing T cell activation, whereas simultaneous engagement of the TCR and CD28 (e.g. by its natural ligands CD80 and CD86 which are expressed on mature antigen presenting cells) leads to activation of resting T lymphocytes (reviewed in [3], [4]).”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [4]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 1×
“CTLA4-deficient mice develop massive lymphoadenopathy, autoimmunity and early deat”
BackgroundSH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222 · cited 1×
“Co-ligation of CTLA4 with TCR, or with TCR and CD28 or TCR and ICOS inhibits proliferatio”
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Research works printed but not linked: 7
- Marinari, B. et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur. J. Immunol. 32, 447–456 (2002). This study shows that dominant-negative forms of VAV can effectively block the induction of nuclear factor-κB (NF-κB) activation through a pathway that involves RAC1. · DOI · Paper page
- Ghaffari-Tabrizi, N. et al. Protein kinase C-θ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29, 132–142 (1999). · DOI · Paper page
- Tuosto, L. et al. Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation. Eur. J. Immunol. 30, 2445–2454 (2000). · DOI · Paper page
- Dimitratos, S. D., Woods, D. F., Stathakis, D. G. & Bryant, P. J. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 21, 912–921 (1999). · DOI · Paper page
- Schneider, H., da Rocha Dias, S., Hu, H. & Rudd, C. E. A regulatory role for cytoplasmic YVKM motif in CTLA-4 inhibition of TCR signaling. Eur. J. Immunol. 31, 2042–2050 (2001). · DOI · Paper page
- Nakaseko, C. et al. Cytotoxic lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 190, 765–774 (1999). · DOI · Paper page
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
“In contrast, receptors like CTLA-4 and PD-1 transduce signals that are inhibitory to lymphocyte activation (27, 55, 55, 57).”
BackgroundCo-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Chen, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1349 · Cited by 1,257
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
“First, none of these receptors has enzymatic activity, but rather their cytoplasmic tails serve as docking stations for signaling proteins that mediate the distinct effects of each of these molecules (2).”
BackgroundYokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161
“Furthermore, PI3K is activated downstream of not only CD28 but also TCR and CTLA-4 (Rudd and Schneider, 2003).”
BackgroundCD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
“The membrane-proximal YXXM motif is shared between CD28, CTLA4, and ICOS and is a consensus site for the p85 subunit of the lipid kinase phosphatidylinositol 3-kinase (PI3K) (August and Dupont, 1994; Pagès et al., 1994; Prasad et al., 1994; Rudd and Schneider, 2003).”
BackgroundInfluentialCD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
“PDK1 and PKB can themselves then phosphorylate and regulate multiple pathways linked to protein synthesis, cellular metabolism, and cell survival (16, 75).”
BackgroundSelf-citationPD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
Reversal of the TCR Stop Signal by CTLA-4
Schneider, H., Downey, J., Smith, A., Zinselmeyer, B. H., Rush, C., Brewer, J. M., Wei, B., Hogg, N., Garside, P., & Rudd, C. E. (2006) · Science · doi:10.1126/science.1131078 · Cited by 621
Self-citationA MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 518
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01011.x · Cited by 391
“On one hand, the binding of Vav with the SH2 leukocyte protein of 76 kDa (SLP-76) ⁄ linker for activated T cells (LAT) complex activates PLCc1 that increases intracellular Ca and triggers PKCh function via the Bcl10 (B-cell lymphoma 10) ⁄MALT1 (mucosal associated lymphoid tissue 1) ⁄CARMA-1 [caspaserecruitment domain…”
BackgroundSantomasso, B., Bachier, C., Westin, J., Rezvani, K., & Shpall, E. J. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238691 · Cited by 330
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Yokosuka, T., Kobayashi, W., Sakata-Sogawa, K., Takamatsu, M., Hashimoto-Tane, A., Dustin, M. L., Tokunaga, M., & Saito, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.011 · Cited by 309
“CD28, which is constitutively expressed on both naive and effector T cells, plays a predominant role in costimulation by binding its ligands, CD80 (B7-1) and CD86 (B7-2) (Acuto and Michel, 2003; Chambers et al., 2001; Rudd and Schneider, 2003; Sharpe and Freeman, 2002).”
BackgroundRegulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
Lee, J. C., Mehdizadeh, S., Smith, J., Young, A., Mufazalov, I. A., Mowery, C. T., Daud, A., & Bluestone, J. A. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba0759 · Cited by 308
“ICOS is an activation marker crucial in the function and identity of active antitumor T cells in the tumor microenvironment (20, 25) and is correlated with the strength of CD28-CD80/86 costimulation signals provided to T cells locally (56, 57).”
BackgroundResultCTLA-4: From mechanism to autoimmune therapy
Hosseini, A., Gharibi, T., Marofi, F., Babaloo, Z., & Baradaran, B. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106221 · Cited by 297
ICOS Co-Stimulation: Friend or Foe?
Wikenheiser, D. J., & Stumhofer, J. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00304 · Cited by 289
“Previously, CD28 ligation had been shown to play a critical role in providing the “second signal” necessary to promote cellular proliferation and survival following T cell activation (2, 3), while CTLA-4 ligation served to mitigate this process (4), as recently reviewed elsewhere (5–7).”
BackgroundInfluentialCTLA4 gene polymorphism and autoimmunity
Gough, S. C. L., Walker, L. S. K., & Sansom, D. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00249.x · Cited by 288
“They share a common motif for the recruitment of P13K, which allows membrane recruitment and activation of proteins such as phosphoinositide-dependent kinase 1, protein kinase B, and glycogen synthase kinase 3, implying a co-receptor role in a number of cellular processes including protein translation and apoptosis (6…”
BackgroundAn Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
“The ability to bind Grb2 is absent from both ICOS and CTLA-4, which may in part explain the signaling and functional differences between these coreceptors (Rudd and Schneider 2003; Rudd et al. 2009).”
BackgroundMethodInfluentialSignaling pathways in Th2 development
Mowen, K. A., & Glimcher, L. H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00209.x · Cited by 255
“expressed on B cells and DCs and is induced by inflammation on non-lymphoid cells (85, 104).”
BackgroundInhibitory Receptors Beyond T Cell Exhaustion
Fuertes Marraco, S. A., Neubert, N. J., Verdeil, G., & Speiser, D. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00310 · Cited by 244
“A prominent example is CTLA-4, which contains a Tyr–Xaa–Xaa–Met motif that is thought to have inhibitory function (12, 24).”
BackgroundMolecular and Cellular Functions of CTLA-4
Van Coillie, S., Wiernicki, B., & Xu, J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3266-5_2 · Cited by 243
Salceda, S., Tang, T., Kmet, M., Munteanu, A., Ghosh, M., Macina, R., Liu, W., Pilkington, G., & Papkoff, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.018 · Cited by 217
Kumar, P., Bhattacharya, P., & Prabhakar, B. S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.007 · Cited by 216
“ICOS, which shares structural similarity with CD28 and CTLA4[48], was first identified in humans[49] and later in mice[50].”
BackgroundYokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto-Tane, A., Yagita, H., Tokunaga, M., & Saito, T. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.006 · Cited by 213
“…of receptors and their downstream signaling molecules, such as zeta-associated protein 70 (Zap70) and SH2-domaincontaining leukocyte protein of 76 kDa (SLP-76), and are formed before cSMAC formation (Bunnell et al., 2002; Campi et al., 2005; Saito and Yokosuka, 2006; Yokosuka et al., 2005).”
Witherden, D. A., Verdino, P., Rieder, S. E., Garijo, O., Mills, R. E., Teyton, L., Fischer, W. H., Wilson, I. A., & Havran, W. L. (2010) · Science · doi:10.1126/science.1192698 · Cited by 210
TRAF6 is a T cell–intrinsic negative regulator required for the maintenance of immune homeostasis
King, C. G., Kobayashi, T., Cejas, P. J., Kim, T., Yoon, K., Kim, G. K., Chiffoleau, E., Hickman, S. P., Walsh, P. T., Turka, L. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1449 · Cited by 206
“T-cell receptor (TCR) ligation in the presence of CD28 costimulation leads to the activation of NF-κB, MAP kinases and Ak”
BackgroundCell Surface Signaling Molecules in the Control of Immune Responses: A Tide Model
Zhu, Y., Yao, S., & Chen, L. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.008 · Cited by 196
Taylor, A., Harker, J. A., Chanthong, K., Stevenson, P. G., Zuniga, E. I., & Rudd, C. E. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.018 · Cited by 190
“In the case of CD28, GSK-3 inactivation involves its binding and activation of phosphatidyl-inositol 3 kinase (PI3K) and protein kinase B (AKT) (Prasad et al., 1994; Rudd and Schneider, 2003).”
Self-citationThe role of B7 family molecules in hematologic malignancy
Greaves, P., & Gribben, J. G. (2013) · Blood · doi:10.1182/blood-2012-10-385591 · Cited by 187
IL-33 in T Cell Differentiation, Function, and Immune Homeostasis
Peine, M., Marek, R. M., & Löhning, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.03.007 · Cited by 179
CTLA-4 trafficking and surface expression
Valk, E., Rudd, C. E., & Schneider, H. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.02.011 · Cited by 177
“Intriguingly, this spectrum of events is mediated by a receptor with a small cytoplasmic tail of only 37 amino acids [29] (Table 1).”
BackgroundSelf-citationMelanoma: Molecular Pathogenesis and Therapeutic Management.
Liu, Y., & Sheikh, M. S. (2014) · PubMed · Cited by 212
Sun, T., Zhou, Y., Yang, M., Hu, Z., Tan, W., Han, X., Shi, Y., Yao, J., Guo, Y., Yu, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0806 · Cited by 160
Takahashi, N., Matsumoto, K., Saito, H., Nanki, T., Miyasaka, N., Kobata, T., Azuma, M., Lee, S., Mizutani, S., & Morio, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803256 · Cited by 173
“M embers of the CD28 family play an important role in the regulation of T cell immune responses (1, 2).”
BackgroundImmune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
Gaikwad, S. R., Agrawal, M. Y., Kaushik, I., Ramachandran, S., & Srivastava, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.014 · Cited by 172
Garçon, F., Patton, D. T., Emery, J. L., Hirsch, E., Rottapel, R., Sasaki, T., & Okkenhaug, K. (2008) · Blood · doi:10.1182/blood-2007-08-108050 · Cited by 153
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
Brunner-Weinzierl, M. C., & Rudd, C. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02737 · Cited by 153
“CD28 plays a central role in providing a second signal needed for T-cell activation (13, 14).”
BackgroundSelf-citationLinterman, M. A., Rigby, R. J., Wong, R. K., Silva, D., Withers, D. R., Anderson, G., Verma, N. K., Brink, R. A., Hutloff, A., Goodnow, C. C., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.015 · Cited by 172
“Biochemically, both Cd28 and Icos encode T cell costimulatory receptors sharing 39% amino acid identity and, in transformed cell lines, largely overlapping capacity to activate the PI3K intracellular signaling pathway and enhance T cell receptor (TCR)-induced gene expression, cytokine synthesis, and cytokine prolifera…”
BackgroundType 1 diabetes genes and pathways shared by humans and NOD mice
Wicker, L. S., Clark, J., Fraser, H. I., Garner, V. E. S., González-Muñoz, A., Healy, B. C., Howlett, S., Hunter, K. M. D., Rainbow, D., Rosa, R. L., et al. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.009 · Cited by 153
Not All Immune Checkpoints Are Created Equal
De Sousa Linhares, A., Leitner, J., Grabmeier-Pfistershammer, K., & Steinberger, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01909 · Cited by 148
“The 36 amino acid cytoplasmic tail of CTLA-4 is highly conserved and interaction with several intracellular signaling molecules has been reported (63).”
BackgroundThe reverse stop-signal model for CTLA4 function
Rudd, C. E. (2008) · Nature reviews. Immunology · doi:10.1038/nri2253 · Cited by 155
Self-citationProteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion
Mythreye, K., & Blobe, G. C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.05.001 · Cited by 141
Emerging paradigms of T-cell co-stimulation
Kroczek, R. A., Mages, H. W., & Hutloff, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.002 · Cited by 157
“More specialized recent reviews focus on the signal transduction properties of T-cell co-stimulators [12,13] and on the different co-stimulation requirements of CD4þ and CD8þ T cells in antiviral immunity [14].”
BackgroundThe Molecular Interaction of CAR and JAML Recruits the Central Cell Signal Transducer PI3K
Verdino, P., Witherden, D. A., Havran, W. L., & Wilson, I. A. (2010) · Science · doi:10.1126/science.1187996 · Cited by 132
Recurrent activating mutations of CD28 in peripheral T-cell lymphomas
Rohr, J. M., Guo, S., Huo, J., Bouska, A. C., Lachel, C. M., Li, Y., Simone, P. D., Zhang, W., Gong, Q., Wang, C., et al. (2015) · Leukemia · doi:10.1038/leu.2015.357 · Cited by 150
T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints
Mirzaei, R., Sarkar, S., & Yong, V. W. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.11.005 · Cited by 147
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Bahlis, N. J., King, A. M., Kolonias, D. S., Carlson, L. M., Liu, H. Y., Hussein, M. A., Terebelo, H. R., Byrne, G. E., Levine, B. L., Boise, L., et al. (2007) · Blood · doi:10.1182/blood-2006-03-012542 · Cited by 145
Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3K
Okkenhaug, K., Ali, K., & Vanhaesebroeck, B. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.007 · Cited by 129
“In peripheral T cells, PI3Ks can be activated by the TCR, by costimulatory receptors such as CD28 and ICOS, and by receptors for cytokines and chemokines [30,69].”
BackgroundCD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells
Guo, F., Iclozan, C., Suh, W.-K., Anasetti, C., & Yu, X.-Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2285 · Cited by 129
“Intracellular domain of CD28 contains multiple motifs that can recruit and activate many kinases, including PI3K, IL-2-inducible T cell kinase (Itk), and Lck, which are responsible for various functions of CD28 receptor (26).”
BackgroundMemory T cells need CD28 costimulation to remember
Boesteanu, A. C., & Katsikis, P. D. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.005 · Cited by 127
“CTLA-4 and ICOS are both structural homologs of CD28, yet they exhibit unique, non-redundant functions upon stimulation [30].”
BackgroundDysregulation of T-Cell Function in the Elderly: Scientific Basis and Clinical Implications
Fülöp, T., Larbi, A., Wikby, A., Mocchegiani, E., Hirokawa, K., & Pawelec, G. (2005) · Drugs & Aging · doi:10.2165/00002512-200522070-00005 · Cited by 131
“[36] Recently, it has Innate and Adaptive Immune Responses been demonstrated that the cell membrane bears The innate immune system modulates adaptive specific microdomains, called lipid rafts, which immunity in several ways.”
BackgroundMarafioti, T., Paterson, J. C., Ballabio, E., Chott, A., Natkunam, Y., Rodriguez‐Justo, M., Plonquet, A., Rodríguez-Pinilla, S. M., Klapper, W., Hansmann, M. L., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.010991 · Cited by 128
“The members of each family have been described to have structural and functional similarities, but also unique features.(12,34) Some of these molecules are constitutively expressed (e.”
BackgroundSchneider, H., Smith, X., Liu, H., Bismuth, G., & Rudd, C. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737423 · Cited by 116
Self-citationOvercoming cold tumors: a combination strategy of immune checkpoint inhibitors
Ouyang, P., Wang, L., Wu, J., Tian, Y., Chen, C., Li, D., Yao, Z., Chen, R., Xiang, G., Gong, J., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1344272 · Cited by 137
“(129).”
CTLA-4 and CD4+CD25+ Regulatory T Cells Inhibit Protective Immunity to Filarial Parasites In Vivo
Taylor, M. D., Harris, A., Babayan, S. A., Bain, O., Culshaw, A., Allen, J. E., & Maizels, R. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4626 · Cited by 116
Antigen-induced regulatory T cells
Vigouroux, S., Yvon, E. S., Biagi, E., & Brenner, M. K. (2004) · Blood · doi:10.1182/blood-2004-01-0182 · Cited by 135
ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
Xiao, Z., Mayer, A. T., Nobashi, T. W., & Gambhir, S. S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3265 · Cited by 121
“Ligation triggers a downstream pathway that regulates T-cell proliferation and survival, as well as secretion of IL4, IL10, and IFN (28, 29).”
BackgroundTavano, R., Gri, G., Molon, B., Marinari, B., Rudd, C. E., Tuosto, L., & Viola, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5392 · Cited by 114
“CD28 stimulation by Abs or B7 results in tyrosine phosphorylation of specific cellular substrates, including Vav-1, PI3K, and the intracellular domain of CD28 itself (5, 9).”
BackgroundSelf-citationLi, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
Dynamic regulation of T‐cell costimulation through TCR–CD28 microclusters
Yokosuka, T., & Saito, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00779.x · Cited by 106
Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells
Choi, Y. S., Kotov, J. A., & Crotty, S. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.04.003 · Cited by 113
Badour, K., McGavin, M. K. H., Zhang, J., Freeman, S., Vieira, C., Filipp, D., Julius, M., Mills, G. B., & Siminovitch, K. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610543104 · Cited by 103
Chen, C., Li, K., Jiang, H., Song, F., Gao, H., Pan, X., Shi, B., Bi, Y., Wang, H., Wang, H., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1949-8 · Cited by 102
Membrane Domains in Lymphocytes – From Lipid Rafts to Protein Scaffolds
Harder, T., & Engelhardt, K. R. (2004) · Traffic · doi:10.1111/j.1600-0854.2003.00163.x · Cited by 115
“In T cells, CD28 provides this essential costimulus (94), whereas in B cells, a second signal is provided by CD19 (95).”
BackgroundT-cell signalling and immune system disorders
Wilkinson, B., Downey, J. S., & Rudd, C. E. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405010264 · Cited by 99
Self-citationIL-21 Sustains CD28 Expression on IL-15-Activated Human Naive CD8+ T Cells
Alves, N. L., Arosa, F. A., & van Lier, R. A. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.755 · Cited by 98
“Upon interaction with its ligands, CD80 and CD86, CD28 transduces activating signals that coupled with TCR signaling promotes entry into cell cycle, survival, and IL-2 production (30).”
BackgroundSo, T., Choi, H., & Croft, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003156 · Cited by 98
“The first- and best-characterized costimulatory molecule, CD28, which is constitutively expressed on T cells, directly recruits the p85a regulatory subunit of PI3K through a pYMNM motif located in the cytoplasmic tail (9, 10).”
BackgroundDynamic regulation of T cell activation and co‐stimulation through TCR‐microclusters
Saito, T., Yokosuka, T., & Hashimoto-Tane, A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.036 · Cited by 98
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor
Ngiow, S. F., Young, A., Blake, S. J., Hill, G. R., Yagita, H., Teng, M. W. L., Korman, A. J., & Smyth, M. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2141 · Cited by 94
Rughetti, A., Pellicciotta, I., Biffoni, M., Bäckström, M., Link, T., Bennet, E. P., Clausen, H., Noll, T., Hansson, G. C., Burchell, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7764 · Cited by 96
The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
Mohseni, Y. R., Tung, S. L., Dudreuilh, C., Lechler, R. I., Fruhwirth, G. O., & Lombardi, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01608 · Cited by 98
Schneider, H., Valk, E., Leung, R., & Rudd, C. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003842 · Cited by 94
Self-citationSemple, K., Nguyen, A., Yu, Y., Wang, H., Anasetti, C., & Yu, X.-Z. (2011) · Blood · doi:10.1182/blood-2010-08-301275 · Cited by 93
“14 activation and survival of T cells.(21,27) On the other hand, CD28 costimulation plays a critical role in development of nTregs in thymus and in maintenance of nTregs in the periphery, by which CD28 contributes to maintaining self-tolerance.”
BackgroundMethodRole of T cell costimulation in anti-viral immunity
Bertram, E. M., Dawicki, W., & Watts, T. H. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.02.006 · Cited by 107
Tai, X., Van Laethem, F., Sharpe, A. H., & Singer, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706509104 · Cited by 91
CD137-mediated immunotherapy for allergic asthma
Polte, T., Foell, J. L., Werner, C., Hoymann, H.-G., Braun, A. C., Burdach, S. E. G., Mittler, O. S., & Hansen, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23792 · Cited by 91
Secretory lysosomes and their cargo in T and NK cells
Lettau, M., Schmidt, H., Kabelitz, D., & Janßen, O. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.10.001 · Cited by 89
CD28 co‐signaling in the adaptive immune response
Riha, P., & Rudd, C. E. (2010) · Self/Nonself · doi:10.4161/self.1.3.12968 · Cited by 87
“Overall, the collective data clearly point to CD28-Grb-2 and Vav1 cooperation in the generation of co-signals and possibly in amplifying TCR signaling.(4,89-91)”
BackgroundSelf-citationAssociation of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA
Gavrieli, M., & Murphy, K. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.036 · Cited by 85
Fukuda, R.-I., Hayashi, A., Utsunomiya, A., Nukada, Y., Fukui, R., Itoh, K., Tezuka, K., Ohashi, K., Mizuno, K., Sakamoto, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507184102 · Cited by 88
Chemnitz, J. M., Lanfranco, A. R., Braunstein, I., & Riley, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6603 · Cited by 85
PKCθ Signals Activation versus Tolerance In Vivo
Berg-Brown, N. N., Gronski, M. A., Jones, R. G., Elford, A. R., Deenick, E. K., Odermatt, B., Littman, D. R., & Ohashi, P. S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031022 · Cited by 85
Hausl, C., Ahmad, R. U., Schwarz, H. P., Muchitsch, E. M., Turecek, P. L., Dorner, F., & Reipert, B. M. (2004) · Blood · doi:10.1182/blood-2003-07-2456 · Cited by 81
Costimulation Signals for Memory CD8+ T Cells During Viral Infections
Duttagupta, P. A., Boesteanu, A. C., & Katsikis, P. D. (2009) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v29.i6.20 · Cited by 81
What makes a good anti-inflammatory drug target?
Simmons, D. L. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03721-9 · Cited by 90
Cell-surface co-receptors: emerging roles in signaling and human disease
Kirkbride, K. C., Ray, B. N., & Blobe, G. C. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.003 · Cited by 99
CTLA-4 (CD152): A versatile receptor for immune-based therapy
Lingel, H., & Brunner-Weinzierl, M. C. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101298 · Cited by 80
Preller, V., Gerber, A., Wrenger, S., Togni, M., Marguet, D., Tadje, J., Lendeckel, U., Röcken, C., Faust, J., Neubert, K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4632 · Cited by 86
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Waibler, Z., Sender, L. Y., Merten, C., Hartig, R., Kliche, S., Gunzer, M., Reichardt, P., Kalinke, U., & Schraven, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001708 · Cited by 79
“(reviewed in [3,4]).”
Sanchez-Lockhart, M., Marin, E., Graf, B., Abe, R., Harada, Y., Sedwick, C. E., & Miller, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7120 · Cited by 79
“However, the biochemical signaling pathways induced downstream of CD28 are still not completely understood (1, 2).”
BackgroundChen, L. C., Delgado, J. C., Jensen, P. E., & Chen, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901081 · Cited by 79
“Activation of all necessary nuclear factors may require costimulation through CD28, which amplifies TCR activation-induced intracellular signaling (58, 59).”
BackgroundInducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen
Kohyama, M., Sugahara, D., Sugiyama, S., Yagita, H., Okumura, K., & Hozumi, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400214101 · Cited by 74
Costimulatory Receptors in a Teleost Fish: Typical CD28, Elusive CTLA4
Bernard, D., Riteau, B., Hansen, J. D., Phillips, R. B., Michel, F., Boudinot, P., & Benmansour, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4191 · Cited by 76
“The presence of this motif in both cytoplasmic tails indicates an overlapping signaling function for CD28 and CTLA4 (56).”
BackgroundLian, J., Liang, Y., Zhang, H., Lan, M., Ye, Z., Lin, B., Qiu, X., & Zeng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912279 · Cited by 84
CD28 and ICOS: Similar or separate costimulators of T cells?
van Berkel, M. E. A. T., & Oosterwegel, M. A. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.02.007 · Cited by 84
The ICOS Molecule Plays a Crucial Role in the Development of Mucosal Tolerance
Miyamoto, K., Kingsley, C. I., Zhang, X., Jabs, C., Izikson, L., Sobel, R. A., Weiner, H. L., Kuchroo, V. K., & Sharpe, A. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7341 · Cited by 76
The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals
Sun, M., Ames, K. T., Suzuki, I., & Fink, P. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1481 · Cited by 73
“Santa Cruz Biotechnology supplied anti-FasL (Q-20), rabbit anti-Grb2 (C-23), anti-Fyn (FYN3), anti-Vav (C-14), anti-p85 PI3K (Z-8), anti-Lck (2102), anti-p-c-Jun (Ser63/ 73), anti-NFATc1 (H-110), and anti-PLC 1 (1249).”
BackgroundInfluential
Metadata
- Authors
- Rudd, C. E., & Schneider, H.
- Affiliations
- Hammersmith Hospital (GB)
- Corresponding author
- Rudd, Christopher E.
- ORCID
- Rudd, Christopher E.
- Venue
- Nature Reviews Immunology
- Published
- 2003-07
- Volume
- 3
- Issue
- 7
- Pages
- 544-556
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2001716606
- Cited by
- 392
- References
- 174
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 12 · 2023: 9 · 2022: 17 · 2021: 15 · 2020: 16 · 2019: 14 · 2018: 13 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 9 · 2013: 19 · 2012: 13
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- CD28, ICOS, CTLA-4, T cell activation, T cell costimulation, T cell tolerance, signaling pathways
- MeSH terms
- Abatacept, Amino Acid Sequence, Animals, Antigens, Differentiation, T-Lymphocyte, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, T-Lymphocytes, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, CD28 Antigens, Immunoconjugates, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, MAP Kinase Kinase Kinase 1, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins c-vav, Inducible T-Cell Co-Stimulator Protein, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.